BeOne Medicines (ONC) EBT Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -5,319.00 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 31,363.00 |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | 1,581.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,006.00 |
| Mar 31, 2026 | 9,237.00 |
| Dec 31, 2025 | 12,335.00 |
| Sep 30, 2025 | 15,263.00 |
| Jun 30, 2025 | 17,081.00 |
| Mar 31, 2025 | 13,925.00 |
| Dec 31, 2024 | 26,667.00 |
| Sep 30, 2024 | 19,997.00 |
| Jun 30, 2024 | 30,900.00 |
| Mar 31, 2024 | -4,260.00 |
| Dec 31, 2023 | 42,620.00 |
| Sep 30, 2023 | 50,700.00 |
| Jun 30, 2023 | 45,292.00 |
| Mar 31, 2023 | 62,278.00 |
| Dec 31, 2022 | 55,514.00 |
| Sep 30, 2022 | 47,979.00 |
| Jun 30, 2022 | -12,879.00 |
| Mar 31, 2022 | 7,789.00 |
| Dec 31, 2021 | 19,492.00 |
| Sep 30, 2021 | 5,767.00 |